Abstract
The role of mast cells in provoking immediate-type hypersensitivity reactions is well established, but their involvement in chronic inflammation and immune reactions is not so clear. Mast cells synthesize and secrete large amounts of active proteinases, including tryptase, chymase, carboxypeptidase and cathepsin G, which can rapidly process numerous biologically active peptides and proteins or their precursors. Furthermore, mast cells are able to produce a variety of cytokines such as interleukin-4 (IL-4), IL-5, IL-6, tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) which are known to be intensively involved in modulating and directing inflammatory responses in the skin. In this review, the role of mast cell proteinases and cytokines in skin inflammation is discussed.
Similar content being viewed by others
References
Schwartz LB, Huff TF (1991) Mast cells. In: Crystal RG, West JB (eds) The lung: scientific foundations. Raven Press, New York, pp 601–616
Harvima RJ, Schwartz LB (1993) Mast cell-derived mediators. In: Foreman J (ed) Immunopharmacology of mast cells and basophils. Academic Press, London, pp 115–138
Gordon JR, Burd PR, Galli SJ (1990) Mast cells as a source of multifunctional cytokines. Immunol Today 11: 458–464
Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991) Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88: 4220–4224
Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST (1992) Interleukin 4 is localized to and released by human mast cells. J Exp Med 176: 1381–1386
Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH (1993) Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: the mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 151: 3853–3865
Eady RAJ, Cowen T, Marshall TF, Plummer V, Greaves MW (1979) Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 100: 623–633
Harvima IT, Naukkarinen A, Harvima RJ, FrÄki JE (1988) Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma cells. Arch Dermatol Res 280: 363–370
Harvima IT, Karkola K, Harvima RJ, Naukkarinen A, NeittaanmÄki H, Horsmanheimo M, FrÄki JE (1989) Biochemical and histochemical evaluation of tryptase in various human tissues. Arch Dermatol Res 281: 231–237
Irani AA, Bradford TR, Kepley CL, Schechter NM, Schwartz LB (1989) Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37: 1509–1515
Schechter NM, Irani AA, Sprows JL, Abernethy J, Wintroub B, Schwartz LB (1990) Identification of a cathepsin G-like proteinase in the MCTC type of human mast cells. J Immunol 145: 2652–2661
Irani AA, Goldstein SM, Wintroub BU, Bradford T, Schwartz LB (1991) Human mast cell carboxypeptidase: selective localization to MCTC cells. J Immunol 147: 247–253
Craig SS, Schechter NM, Schwartz LB (1988) Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest 58: 682–691
Craig SS, Schwartz LB (1990) Human MCTC type of mast cell granule: the uncommon occurrence of discrete scrolls associated with focal absence of chymase. Lab Invest 63: 581–585
Weidner N, Austen KF (1993) Heterogeneity of mast cells at multiple body sites: fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract 189: 156–162
Harvima IT, Naukkarinen A, Paukkonen K, Harvima RJ, Aalto M-L, Schwartz LB, Horsmanheimo M (1993) Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 285: 184–192
Schwartz LB, Irani AA, Roller K, Castells M, Schechter NM (1987) Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol 138: 2611–2615
Goldstein SM, Leong J, Schwartz LB, Cooke D (1992) Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes: tryptase resides in a complex distinct from chymase and carboxypeptidase. J Immunol 148: 2475–2482
Whitaker-Menezes D, Schechter NM, Murphy GF (1993) Localization of cathepsin G to cutaneous mast cell granules: evidence for regional segregation of mast cell proteinases. Clin Res 41: 473A
Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC (1989) Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 88: 70–78
Church MK, El-Lati S, Okayama Y (1991) Biological properties of human skin mast cells. Clin Exp Allergy 21: 1–9
Lowman MA, Rees PH, Benyon C, Church MK (1988) Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 81: 590–597
Kubota Y (1992) The effect of human anaphylatoxins and neutrophils on histamine release from isolated human skin mast cells. J Dermatol 19: 19–26
Overveld FJ van, Jorens PhG, Rampart M, De Backer W, Vermeire PA (1991) Tumor necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 21: 711–714
Subramanian N, Bray MA (1987) Interleukin-1 releases histamine from human basophils and mast cells in vitro. J Immunol 138: 271–275
Brody I (1984) Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 82: 460–464
Schubert C, Christophers E (1985) Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 277: 352–358
Toruniowa B, Jablonska S (1988) Mast cells in the initial stages of psoriasis. Arch Dermatol Res 280: 189–193
Harvima IT, Naukkarinen A, Harvima RJ, Horsmanheimo M (1989) Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin. Arch Dermatol Res 281: 387–391
Harvima IT, Naukkarinen A, Harvima RJ, Aalto M-L, NeittaanmÄki H, Horsmanheimo M (1991) Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus. Acta Derm Venereol (Stockh) 71: 394–398
Mihm MC, Soter NA, Dvorak HF, Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67: 305–312
Mitchell EB, Crow J, Williams G, Platts-Mills TAE (1986) Increase in skin mast cells following chronic house dust mite exposure. Br J Dermatol 114: 65–73
Sugiura H, Hirota Y, Uehara M (1989) Heterogeneous distribution of mast cells in lichenified lesions of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 144: 115–118
Irani AA, Sampson HA, Schwartz LB (1989) Mast cells in atopic dermatitis. Allergy 44 [Suppl 9]: 31–34
Nishioka K, Kobayashi Y, Katayama I, Takijiri C (1987) Mast cell numbers in diffuse scleroderma. Arch Dermatol 123: 205–208
Claman HN (1989) On scleroderma: mast cells, endothelial cells, and fibroblasts. JAMA 262: 1206–1209
Torinuki W, Kudoh K, Tagami H (1989) Increased mast cell numbers in the sclerotic skin of porphyria cutanea tarda. Dermatologica 178: 75–78
Irani AA, Gruber BL, Kaufman LD, Kahaleh MB, Schwartz LB (1992) Mast cell changes in scleroderma: presence of MCT cells in the skin and evidence of mast cell activation. Arthritis Rheum 35: 933–939
Reich JD, Cazzaniga AL, Mertz PM, Kerdel FA, Eaglstein WH (1991) The effect of electrical stimulation on the number of mast cells in healing wounds. J Am Acad Dermatol 25: 40–46
Bolton LL, Montagna W (1993) Mast cells in human ulcers. Am J Dermatopathol 15: 133–138
Lavker RM, Kligman AM (1988) Chronic heliodermatitis: a morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. J Invest Dermatol 90: 325–330
Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki BM (1981) Electron microscopical evidence for a direct contact between nerve fibers and mast cells. Acta Derm Venereol (Stockh) 61: 465–469
Bienenstock J, Tomioka M, Matsuda H, Stead RH, Quinonez G, Simon GT, Coughlin MD, Denburg JA (1987) The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol 82: 238–243
Gazelius B, Brodin E, Olgart L, Panopoulos P (1981) Evidence that substance P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitor. Acta Physiol Scand 113: 155–159
Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC (1991) Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44: 97–112
MacQueen G, Marshall J, Perdue M, Siegel S, Bienenstock J (1989) Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 243: 83–85
Wallengren J (1990) Sensory neuromediators in human skin: role in inflammation and other disorders. Doctoral Thesis. Department of Dermatology, Lund University, Malmö, Sweden. Lindbergs Blankett, Skurup
Caughey GH, Leidig F, Viro NF, Nadel JA (1988) Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 244: 133–137
Tam EK, Caughey GH (1990) Degradation of airway neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 3: 27–32
Travis J, Reilly C (1985) The role of leukocyte cathepsin G and chymase in inflammation. In: Ogawa H, Lazarus GS, Hopsu-Havu VK (eds) The biological role of proteinases and their inhibitors in skin. University of Tokyo Press, Tokyo, pp 121–125
Walls AF, Brain SD, Desai A, Jose PJ, Hawkins E, Church MK, Williams TJ (1992) Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem Pharmacol 43: 1243–1248
Franconi GM, Graf PD, Lazarus SC, Nadel JA, Caughey GH (1989) Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret. J Pharmacol Exp Ther 248: 947–951
Harvima IT, Schechter NM, Harvima RJ, FrÄki JE (1988) Human skin tryptase: purification, partial characterization and comparison with human lung tryptase. Biochim Biophys Acta 957: 71–80
Alter SC, Kramps JA, Janoff A, Schwartz LB (1990) Interactions of human mast cell tryptase with biological protease inhibitors. Arch Biochem Biophys 276: 26–31
Harvima IT, Harvima RJ, Eloranta TO, FrÄki JE (1988) The allosteric effect of salt on human mast cell tryptase. Biochim Biophys Acta 956: 133–139
Schechter NM, Sprows JL, Schoenberger OL, Lazarus GS, Cooperman BS, Rubin H (1989) Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem 264: 21308–21315
Harvima IT, Naukkarinen A, Harvima RJ, Aalto M-L, NeittaanmÄki H, Horsmanheimo M (1990) Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 282: 428–433
Naukkarinen A, Harvima IT, Aalto M-L, Harvima RJ, Horsmanheimo M (1991) Quantitative analysis of contact sites between mast cells and sensory nerves in cutaneous psoriasis and lichen planus based on a histochemical double staining technique. Arch Dermatol Res 283: 433–437
Naukkarinen A, Nickoloff BJ, Farber EM (1989) Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 92: 126–129
Naukkarinen A, Harvima I, Paukkonen K, Aalto M-L, Horsmanheimo M (1993) Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 285: 341–346
Naukkarinen A, Harvima IT, Aalto M-L, Horsmanheimo M (1994) Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Int J Dermatol 33: 361–366
Harvima IT, ViinamÄki H, Naukkarinen A, Paukkonen K, NeittaanmÄki H, Harvima RJ, Horsmanheimo M (1993) Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. Psychother Psychosom 60: 168–176
Irani AA, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwartz LB (1992) Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80: 3009–3021
Sillaber C, Strobl H, Bevec D, Ashman LK, Butterfield JH, Lechner K, Maurer D, Bettelheim P, Valent P (1991) IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 147: 4224–4228
Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS (1991) Rapid and specific conversion of precursor interleukin 1Β (IL-1Β) to an active IL-1 species by human mast cell chymase. J Exp Med 174: 821–825
Maier M, Spragg J, Schwartz LB (1983) Inactivation of human high molecular weight kininogen by human mast cell tryptase. J Immunol 130: 2352–2356
Schwartz LB, Bradford TR, Littman BH, Wintroub BU (1985) The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 135: 2762–2767
Harvima IT, Harvima RJ, PenttilÄ IM, Eloranta TO, Horsmanheimo M, FrÄki JE (1989) Effect of human mast cell tryptase on human plasma proenzymes. Int Arch Allergy Appl Immunol 90: 104–108
Lohi J, Harvima I, Keski-Oja J (1992) Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem 50: 337–349
Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, Clapham PR, McKeating JA, McClure MO, Thomson S, Marsh M, Kay J, Weiss RA, Moore JP (1991) The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res Hum Retro viruses 7: 3–16
Harvima IT, Harvima RJ, Nilsson G, Ivanoff L, Schwartz LB (1993) Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein. Biochem J 292: 711–718
Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127: 871–884
Cooper KD (1994) Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 102: 128–137
Ansel JC, Brown JR, Payan DG, Brown MA (1993) Substance P selectively activates TNF-α gene expression in murine mast cells. J Immunol 150: 4478–4485
Piguet PF, Grau GE, Hauser C, Vassalli P (1991) Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 173: 673–679
Ioffreda MD, Whitaker D, Murphy GF (1993) Mast cell degranulation upregulates α6 integrins on epidermal Langerhans cells. J Invest Dermatol 101: 150–154
Horsmanheimo L, Harvima IT, JÄrvikallio A, Harvima RJ, Naukkarinen A, Horsmanheimo M (1994) Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 131: 348–353
Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA Jr, McIntyre BW, Bochner BS (1992) IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 148: 1086–1092
Swain SL, Weinberg AD, English M, Huston G (1990) IL-4 directs the development of Th2-like helper effectors. J Immunol 145: 3796–3806
van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS, Maggi E, Romagnani S, Westland JKT, Mudde GC (1992) Skin-derived aeroallergen-specific T-cells clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90: 184–192
Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C (1992) House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 89: 801–810
Punnonen J, Punnonen K, Jansén CT, Kalimo K (1993) Interferon (IFN)-α, IFN-γ, interleukin (IL)-2, and arachidonic acid metabolites modulate IL-4-induced IgE synthesis similarly in healthy persons and in atopic dermatitis patients. Allergy 48: 189–195
Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in lesional and lesionfree psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101: 701–705
Horsmanheimo L, Harvima IT, Harvima RJ, Naukkarinen A, Horsmanheimo M (1994) Interferon-gamma in mast cells of psoriatic skin (abstract). The International Symposium on Mast Cells in Skin Diseases, 10–11 June 1994, Lübeck, Germany. Allergologie 17: S225, 1994
Paukkonen K, Naukkarinen A, Horsmanheimo M (1994) The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch Dermatol Res (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harvima, I.T., Horsmanheimo, L., Naukkarinen, A. et al. Mast cell proteinases and cytokines in skin inflammation. Arch Dermatol Res 287, 61–67 (1994). https://doi.org/10.1007/BF00370720
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00370720